Repository of Research and Investigative Information

Repository of Research and Investigative Information

Kurdistan University of Medical Sciences

Adverse events following immunization with pentavalent vaccine: Experiences of newly introduced vaccine in Iran

(2017) Adverse events following immunization with pentavalent vaccine: Experiences of newly introduced vaccine in Iran. BMC Immunology.

Full text not available from this repository.

Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

Background: The most important factors that affect the incidence of vaccine-related complications are the constituent biological components of the vaccine, injection site reactions, age and sex. The aim of this study is to determine the incidence rate of adverse events following immunization with pentavalent vaccine (DTPw-Hep B-Hib (PRP-T) vaccine (pentavac) (adsorbed) is manufactured by Serum Institute of India ltd), which was introduced in Iran in November 2014. It is important to monitor vaccine-related adverse events because of the role of vaccine safety in immunization program success. Methods: This study was a mixed cohort study that included 1119 children less than 1 year of age. In 2015, the children were referred to Hamadan health centers to receive pentavalent vaccine at 2, 4 and 6 months of age. The data were collected from the parents of the children using a questionnaire that was administered either face-to-face or by telephone. The cumulative incidence of side effects and risk ratio was reported with 95 confidence intervals (CI). Chi-squared tests and logistic regressions were used to investigate the association between the variables. Results: The cumulative incidence rate of pentavalent-related adverse events during 48 h following immunization was estimated to be 15.8 for swelling, 10.9 for redness, 44.2 for pain, 12.6 for mild fever, 0.1 for high fever, 20.0 for drowsiness, 15.0 for loss of appetite, 32.9 for irritability, 4.6 for vomiting and 5.5 for persistent crying. There is no evidence for the occurrence of convulsion and encephalopathy among children who receive pentavalent vaccines. Conclusion: Further large studies with long time follow up are required to address rare events include convulsions, encephalopathy or persistent crying. However, Findings urge immunization programs to use pentavalent vaccinations and to continue implementing the current immunization program in children under 1 year of age. © 2017 The Author(s).

Item Type: Article
Keywords: diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b vaccine, age; anorexia; Article; brain disease; cohort analysis; controlled study; convulsion; crying; drowsiness; drug safety; female; fever; human; immunization; incidence; infant; Iran; irritability; knowledge; loss of appetite; major clinical study; male; pain; restlessness; sex difference; side effect; swelling; vaccination; vomiting
Journal or Publication Title: BMC Immunology
Volume: 18
Number: 1
Publisher: BioMed Central Ltd.
Identification Number: 10.1186/s12865-017-0226-8
ISSN: 14712172
Depositing User: مهندس مهدی شریفی
URI: http://eprints.muk.ac.ir/id/eprint/193

Actions (login required)

View Item View Item